Lori Calabrese, MD
Lori Calabrese, MD was educated at The Johns Hopkins University School of Medicine, completed residency training at Massachusetts General Hospital/Harvard Medical School. She served as clinical faculty at MGH/Harvard Medical School and as Clinical Assistant Professor of Psychiatry at Yale. She loves patient care, and has worked in private practice in the Hartford area for more than 20 years. Dr. Calabrese was the first physician in CT to offer IV ketamine infusions for treatment resistant depression in her practice, Innovative Psychiatry, as part of a full array of psychiatric treatment options in an office setting. She has a keen interest in treating acute and chronic suicidal ideation with ketamine infusions. In 2018, she presented preliminary data using IV ketamine to treat suicidal outpatients in psychiatric private practice at the First International Conference for Ketamine and Related Compounds for Psychiatric Disorders in Oxford, UK. She has presented the results of her ongoing work using serial, titrated ketamine infusions for suicidal ideation at KRIYA Conference 2018 in San Francisco, California, at the 6th World Congress on Mental Health, Psychiatry and Wellbeing 2019 in New York, and at the APA 2019 Annual Meeting in San Francisco. She will also be speaking at the 2019 International Summit on Suicide Research in Miami in October, 2019.
Gerard Sanacora, PhD, MD
George D. and Esther S. Gross Professor of Psychiatry; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service
Dr. Sanacora is currently an Associate Professor and the Director of the Yale Depression Research Program. Dr. Sanacora’s work is concentrated largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders. Much of his recent research has focused on identifying the contributions of the amino acid neurotransmitter systems (GABA and Glutamate) to the neurobiology of mood disorders and the mechanism of antidepressant action.
Amit Anand, MD
Professor of Medicine at the Cleveland Clinic Lerner College of Medicine
Professor of Medicine at the Cleveland Clinic Lerner College of Medicine; Vice-chair for Research for the Center for Behavioral Health; Director, Mood and Emotional Disorders Across the Life Span (MEDALS) program, Cleveland Clinic
Jeffrey Becker, MD
Adult Psychiatry and Wellness
Dr. Jeffrey Becker trained at UCLA/NPI in both Medicine and Psychiatry with a focus on Neuropsychiatry and Functional Medicine. He is board-certified through the American Board of Psychiatry and Neurology (ABPN) and the American Board for Integrative and Holistic Medicine (ABIHM). He maintains clinical offices in Los Angeles and Santa Barbara and is affiliated with UCLA/NPI as Volunteer Clinical Faculty.
Dr. Becker’s integrative and holistic approach to psychiatry examines mind and brain function in reference to the health of the whole body. He combines conventional medicine with evidence-based nutrients, lifestyle modifications, and complimentary treatments to restore synergy and balance to baseline physiology.
Clinical presentation, past medical history, laboratory results and genetic studies are examined to customize an individualized treatment plan designed specifically to promote optimal health and improve medical and psychiatric outcomes for each patient.
Rachel Dalthorp M.D.
Diplomate American Board of Psychiatry and Neurology
Dr. Rachel Dalthorp received her medical degree from the University of Oklahoma College of Medicine in 2010 followed by a a four-year psychiatric residency where she focused on developing expertise in the sub-specialty of reproductive psychiatry. She owns a private practice in the Oklahoma City area called Balance Women’s Health.
In 2015 she developed an interest in interventional treatments for psychiatric disorders, specifically treatment resistant depression, and began providing ketamine infusion therapy. Dr. Dalthorp has provided more than 4000 infusions. Her expertise in hormone related mood disorders and experience treating patients with Ketamine infusions led to an interest in understanding how hormones might impact infusion results and efforts to modify treatment to improve response rates.
Jessica Katzman, Psy.D
Dr. Jessica Katzman, Psy.D. is a Clinical Psychologist licensed in California. She co-founded Healing Realms, a center for depth-oriented ketamine assisted psychotherapy, with Dr. Robert Grant in 2017, following an advanced training in therapeutic ketamine with the KRIYA Institute. She also organizes a local consultation group for ketamine assisted psychotherapy providers in the Bay Area.
Dr. Katzman has 20 years of experience as a therapist and supervisor, including a decade providing harm reduction and disability evaluation services in a community mental health setting. In her private practice, she specializes in mood and anxiety disorders, chronic and complex PTSD, addressing alcohol and substance use from a harm reduction lens, supporting the LGBTQ community, assessments for gender transition procedures, and assisting those integrating psychedelic experiences.
Sanjay Mathew, MD
Vice Chair for Research; Baylor College of Medicine; Professor of Psychiatry and Behavioral Sciences; Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Chair for Research in Psychiatry; Menninger Department of Psychiatry & Behavioral Sciences; Baylor College of Medicine; Houston, TX, US; Director; Mood and Anxiety Disorders Program; Baylor College of Medicine; Houston, Texas, United States; Staff Physician; Michael E. DeBakey VA Medical Center;
Daniel Richman, MD
Anesthesiologist and Pain Management Physician
Attending Anesthesiologist and Pain Management Physician - Hospital for Special Surgery Assistant Attending and Clinical Instructor - Tri-Institutional Pain Management Fellowship, New York-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.
Omid J Naim, M.D.
Founder & Director, Psychiatry
As the founder of La Maida Institute, Omid is proud to share his vision of a “communal model for preventive health.” On a day-to-day basis, he moves between seeing patients in his clinic, Hope Integrative Psychiatry, and serving as the creative director of La Maida, supporting its growth and development through collaboration and teamwork.
David Sheehan, M.D., M.B.A.
Distinguished University Health Professor Emeritus
David V. Sheehan M.D., M.B.A. is recognized as one of the world’s leading researchers in anxiety disorders. He has written over 500 abstracts and 300 publications including a bestseller The Anxiety Disease.